ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,101Medicare Part D Prescriptions Filled, Including Refills

Rank: 417 out of 2588

$383K Total Retail Price of All Prescriptions

Rank: 743 out of 2588

242 Patients Receiving at Least One Drug in Part D
21%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 242 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 2,094 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 660 177 1 1
ENALAPRIL MALEATE 404 166 2 31
OMEPRAZOLE 316 100 3 6
METFORMIN HCL 256 27 4 8
RANITIDINE HCL 250 50 5 37
LEVOTHYROXINE SODIUM 228 37 6 2
IBUPROFEN 210 44 7 62
AMLODIPINE BESYLATE 197 19 8 4
LISINOPRIL 195 42 9 3
METOPROLOL TARTRATE 167 28 10 9
CLOZAPINE 157 0 11 163
OXYBUTYNIN CHLORIDE ER 149 46 12 85
TRIAMTERENE-HCTZ 147 35 13 46
ATORVASTATIN CALCIUM 132 20 14 11
CLONIDINE HCL 131 43 15 54
RISPERIDONE 131 13 15 57
HYDROCHLOROTHIAZIDE 117 43 17 13
FAMOTIDINE 105 48 18 36
FENOFIBRATE 103 13 19 64
LEVETIRACETAM 103 42 19 90
PHENYTOIN SODIUM EXTENDED 103 38 19 109
CYCLOBENZAPRINE HCL 103 31 R 19 87
NIFEDIPINE ER 101 38 23 59
ALENDRONATE SODIUM 100 32 24 21
DIVALPROEX SODIUM 100 0 24 89
DIOVAN 95 40 26 29
FUROSEMIDE 89 31 27 5
ATENOLOL 88 26 28 14
TAMSULOSIN HCL 85 46 29 23
DESMOPRESSIN ACETATE 82 0 30 345
DIVALPROEX SODIUM ER 81 13 31 121
GLIPIZIDE 77 0 32 44
ABILIFY 73 0 33 134
TRIAMCINOLONE ACETONIDE 72 16 34 106
VESICARE 72 0 34 172
POTASSIUM CHLORIDE 69 25 36 15
ACTOS 67 19 37 105
FLUOXETINE HCL 64 0 38 92
LITHIUM CARBONATE 64 13 38 229
CARBAMAZEPINE 64 12 38 146
TRAMADOL HCL 64 33 38 19
METOPROLOL SUCCINATE 63 18 42 12
GLIPIZIDE ER 61 0 43 73
LACTULOSE 60 27 44 135
LIPITOR 57 0 45 114
QUETIAPINE FUMARATE 55 16 46 74
PRAVASTATIN SODIUM 55 12 46 16
PAROXETINE HCL 54 0 48 71
BACLOFEN 54 11 48 142
NYSTOP 54 0 48 242
WARFARIN SODIUM 54 0 48 10
CARVEDILOL 53 12 52 20
BUSPIRONE HCL 52 26 53 173
LOVASTATIN 52 12 53 34
SERTRALINE HCL 51 25 55 26
FLUTICASONE PROPIONATE 50 0 56 40
AMOXICILLIN 50 11 56 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.